(Q33293362)

25 July 2017

1 reference

title

CB1 receptors: emerging evidence for central and peripheral mechanisms that regulate energy balance, metabolism, and cardiovascular health (English)

1 reference

25 July 2017

1 reference

Daniela Cota

1

1 reference

25 July 2017

1 October 2007

1 reference

Diabetes - Metabolism: Research and Reviews

25 July 2017

1 reference

25 July 2017

23

1 reference

25 July 2017

507-517

1 reference

25 July 2017

7

1 reference

Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state.

25 July 2017

1 reference

Role of endogenous cannabinoids in synaptic signaling

21 January 2018

1 reference

Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice

21 January 2018

1 reference

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

21 January 2018

1 reference

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

7 January 2021

Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association

1 reference

7 January 2021

Abdominal obesity and metabolic syndrome

1 reference

7 January 2021

Excess deaths associated with underweight, overweight, and obesity

1 reference

7 January 2021

Mechanisms linking obesity with cardiovascular disease

1 reference

7 January 2021

Cannabis: Effects on hunger and thirst

1 reference

7 January 2021

Hunger and appetite after single doses of marihuana, alcohol, and dextroamphetamine

1 reference

7 January 2021

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

1 reference

7 January 2021

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1 reference

7 January 2021

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

7 January 2021

The invertebrate ancestry of endocannabinoid signalling: an orthologue of vertebrate cannabinoid receptors in the urochordate Ciona intestinalis.

1 reference

7 January 2021

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

1 reference

7 January 2021

The emerging role of the endocannabinoid system in endocrine regulation and energy balance

1 reference

7 January 2021

Role of the endogenous cannabinoid system in the regulation of motor activity.

1 reference

7 January 2021

Endocannabinoid control of food intake and energy balance

1 reference

7 January 2021

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors

1 reference

7 January 2021

Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action.

1 reference

7 January 2021

Distribution of cannabinoid receptor messenger RNA in the human brain: an in situ hybridization histochemistry with oligonucleotides.

1 reference

7 January 2021

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

1 reference

7 January 2021

The functional neuroanatomy of brain cannabinoid receptors.

1 reference

7 January 2021

Modulation of transmitter release via presynaptic cannabinoid receptors

1 reference

7 January 2021

In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum

1 reference

7 January 2021

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

1 reference

7 January 2021

Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice

1 reference

7 January 2021

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

1 reference

7 January 2021

The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells

1 reference

7 January 2021

Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell.

1 reference

7 January 2021

Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations

1 reference

7 January 2021

Identification and functional characterization of brainstem cannabinoid CB2 receptors

1 reference

7 January 2021

Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain

1 reference

7 January 2021

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

7 January 2021

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

1 reference

7 January 2021

2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor

1 reference

7 January 2021

Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor

1 reference

7 January 2021

N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo

1 reference

7 January 2021

The molecular logic of endocannabinoid signalling

1 reference

7 January 2021

Brain monoglyceride lipase participating in endocannabinoid inactivation

1 reference

7 January 2021

Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds

1 reference

7 January 2021

Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells

1 reference

7 January 2021

Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function.

1 reference

7 January 2021

A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.

1 reference

7 January 2021

Binding of anandamide to bovine serum albumin

1 reference

7 January 2021

Enhancement of brain [3H]flunitrazepam binding and analgesic activity of synthetic cannabimimetics

1 reference

7 January 2021

Enantiomeric cannabinoids: stereospecificity of psychotropic activity

1 reference

7 January 2021

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

1 reference

7 January 2021

123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors.

1 reference

7 January 2021

Imaging the brain marijuana receptor: development of a radioligand that binds to cannabinoid CB1 receptors in vivo.

1 reference

7 January 2021

Functional role of high-affinity anandamide transport, as revealed by selective inhibition

1 reference

7 January 2021

Modulation of anxiety through blockade of anandamide hydrolysis

1 reference

7 January 2021

Kinetic studies of food intake and sucrose solution preference by rats treated with low doses of delta9-tetrahydrocannabinol

1 reference

7 January 2021

Hyperphagia in pre-fed rats following oral delta9-THC.

1 reference

7 January 2021

Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine

1 reference

7 January 2021

Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors

1 reference

7 January 2021

Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice.

1 reference

7 January 2021

Consumption of high carbohydrate, high fat, and normal chow is equally suppressed by a cannabinoid receptor antagonist in non-deprived rats

1 reference

7 January 2021

Appetite suppression and weight loss after the cannabinoid antagonist SR 141716.

1 reference

7 January 2021

Effects of the cannabinoid antagonists AM281 and AM630 on deprivation-induced intake in Lewis rats.

1 reference

7 January 2021

Leptin-regulated endocannabinoids are involved in maintaining food intake

1 reference

7 January 2021

CB1 cannabinoid receptor-mediated modulation of food intake in mice

1 reference

7 January 2021

Monitoring of stored and available fuel by the CNS: implications for obesity

1 reference

7 January 2021

Central nervous system control of food intake

1 reference

7 January 2021

The neuroanatomical axis for control of energy balance

1 reference

7 January 2021

Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats

1 reference

7 January 2021

Endocannabinoid signaling system and brain reward: emphasis on dopamine

1 reference

7 January 2021

Cannabinoids, opioids and eating behavior: the molecular face of hedonism?

1 reference

7 January 2021

Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol

1 reference

7 January 2021

Delta(9)-THC stimulates food intake in Lewis rats: effects on chow, high-fat and sweet high-fat diets

1 reference

7 January 2021

Observational analysis of feeding induced by Delta9-THC and anandamide

1 reference

7 January 2021

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors.

1 reference

7 January 2021

Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats.

1 reference

7 January 2021

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study

1 reference

7 January 2021

Cannabinoids and reward: interactions with the opioid system.

1 reference

7 January 2021

Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit

1 reference

7 January 2021

The cannabinoid CB1 receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin.

1 reference

7 January 2021

Hypersensitization of the Orexin 1 receptor by the CB1 receptor: evidence for cross-talk blocked by the specific CB1 antagonist, SR141716

1 reference

7 January 2021

The wake-promoting peptide orexin-B inhibits glutamatergic transmission to dorsal raphe nucleus serotonin neurons through retrograde endocannabinoid signaling.

1 reference

7 January 2021

Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism.

1 reference

7 January 2021

Evidence for an interaction between CB1 cannabinoid and melanocortin MCR-4 receptors in regulating food intake.

1 reference

7 January 2021

Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain.

1 reference

7 January 2021

Effects of the cannabinoid receptor antagonist SR 141716, alone and in combination with dexfenfluramine or naloxone, on food intake in rats

1 reference

7 January 2021

The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract

1 reference

7 January 2021

Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin.

1 reference

7 January 2021

Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats.

1 reference

7 January 2021

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity

1 reference

7 January 2021

The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance

1 reference

7 January 2021

Role of cannabinoid CB2 receptors in glucose homeostasis in rats

1 reference

7 January 2021

Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia

1 reference

7 January 2021

Activation of the peripheral endocannabinoid system in human obesity

1 reference

7 January 2021

Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity

1 reference

7 January 2021

Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men.

1 reference

7 January 2021

Blood levels of the endocannabinoid anandamide are increased in anorexia nervosa and in binge-eating disorder, but not in bulimia nervosa

1 reference

7 January 2021

Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets

1 reference

7 January 2021

Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH).

1 reference

7 January 2021

Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use.

1 reference

7 January 2021

Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: differences between restricting and binging/purging subtypes

1 reference

7 January 2021

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

1 reference

7 January 2021

Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial

1 reference

7 January 2021

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

1 reference

7 January 2021

Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men

1 reference

7 January 2021

The anti-obesity effect of rimonabant is associated with an improved serum lipid profile

1 reference

7 January 2021

Antiobesity effects of chronic cannabinoid CB1 receptor antagonist treatment in diet-induced obese mice

1 reference

7 January 2021

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

1 reference

7 January 2021

Adiponectin: action, regulation and association to insulin sensitivity

1 reference

7 January 2021

Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men.

1 reference

7 January 2021

Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue.

1 reference

7 January 2021

Endothelial dysfunction, inflammation, and insulin resistance: a focus on subjects at risk for type 2 diabetes

1 reference

7 January 2021

C-reactive protein levels and outcomes after statin therapy

1 reference

7 January 2021

Weight loss reduces C-reactive protein levels in obese postmenopausal women

1 reference

7 January 2021

Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.764

1 reference

25 July 2017

1 reference

PubMed ID

17683024